NCT00003516 2018-02-05
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
Burzynski Research Institute
Phase 2 Terminated
Clinical Trials
5 trialsNCT00003534 2018-01-31
Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer
Burzynski Research Institute
Phase 2 Withdrawn
NCT00003533 2017-12-12
Antineoplaston Therapy in Treating Patients With Metastatic Prostate Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00003520 2017-09-29
Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00003517 2013-07-10
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Withdrawn